Allogene Therapeutics
ALLO
ALLO
168 hedge funds and large institutions have $686M invested in Allogene Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 67 increasing their positions, 55 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
12% less funds holding
Funds holding: 191 → 168 (-23)
40% less capital invested
Capital invested by funds: $1.15B → $686M (-$461M)
50% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 40
Holders
168
Holding in Top 10
2
Calls
$621K
Puts
$400K
Top Buyers
| 1 | +$15.6M | |
| 2 | +$11.8M | |
| 3 | +$5.88M | |
| 4 |
Two Sigma Investments
New York
|
+$4.9M |
| 5 |
Two Sigma Advisers
New York
|
+$4.64M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$8.47M | |
| 3 | -$5.47M | |
| 4 |
Goldman Sachs
New York
|
-$4.92M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.3M |